The DOI matches its Crossref record; 225 of the 225 references it cites were found in a registry or an index.
In vitro Models of Neurodegenerative Diseases
Open accessAbstract
Neurodegenerative diseases are progressive degenerative conditions characterized by the functional deterioration and ultimate loss of neurons. These incurable and debilitating diseases affect millions of people worldwide, and therefore represent a major global health challenge with severe implications for individuals and society. Recently, several neuroprotective drugs have failed in human clinical trials despite promising pre-clinical data, suggesting that conventional cell cultures and animal models cannot precisely replicate human pathophysiology. To bridge the gap between animal and human studies, three-dimensional cell culture models have been developed from human or animal cells, allowing the effects of new therapies to be predicted more accurately by closely replicating some aspects of the brain environment, mimicking neuronal and glial cell interactions, and incorporating the effects of blood flow. In this review, we discuss the relative merits of different cerebral models, from traditional cell cultures to the latest high-throughput three-dimensional systems. We discuss their advantages and disadvantages as well as their potential to investigate the complex mechanisms of human neurodegenerative diseases. We focus on in vitro models of the most frequent age-related neurodegenerative disorders, such as Parkinson’s disease, Alzheimer’s disease and prion disease, and on multiple sclerosis, a chronic inflammatory neurodegenerative disease affecting young adults.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–225 of 225
Li, T., Pires, C., Nielsen, T. T., Waldemar, G., Hjermind, L. E., Nielsen, J. E., Dinnyés, A., Hyttel, P., & Freude, K. (2016) · Stem Cell Research · doi:10.1016/j.scr.2016.01.002 · Cited by 33
Szlachcic, W. J., Wiatr, K., Trzeciak, M., Figlerowicz, M., & Figiel, M. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00253 · Cited by 32
Tan, G. A., Furber, K. L., Thangaraj, M. P., Sobchishin, L., Doucette, J. R., & Nazarali, A. J. (2017) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-017-0529-6 · Cited by 31
Zollo, A., Allen, Z., Rasmussen, H. F., Iannuzzi, F., Shi, Y., Larsen, A., Maier, T. J., & Matrone, C. (2017) · Neural Plasticity · doi:10.1155/2017/1892612 · Cited by 30
Erratum: An in vivo model of functional and vascularized human brain organoids
Mansour, A. A., Gonçalves, J. T., Bloyd, C. W., Li, H., Fernandes, S., Quang, D., Johnston, S. T., Parylak, S., Jin, X., & Gage, F. H. (2018) · Nature Biotechnology · doi:10.1038/nbt0818-772e · Cited by 29
Epigenetic Enzymes, Age, and Ancestry Regulate the Efficiency of Human iPSC Reprogramming
Mackey, L. C., Annab, L. A., Yang, J., Rao, B., Kissling, G. E., Schurman, S. H., Dixon, D., & Archer, T. (2018) · Stem Cells · doi:10.1002/stem.2899 · Cited by 28
Purification and Culture of Oligodendrocyte Lineage CellsPreprint
Dugas, J. C., & Emery, B. (2013) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top074898 · Cited by 27
Organotypic Co‐Cultures of Rat Locus Coeruleus and Hippocampus
Knöpfel, T., Rietschin, L., & Gähwiler, B. H. (1989) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1989.tb00374.x · Cited by 26
Zhang, Q., Li, J.-J., Lin, X., Lu, Y., Guo, X.-X., Dong, E., Zhao, M., He, J., Wang, N., & Chen, W. (2017) · Oncotarget · doi:10.18632/oncotarget.14641 · Cited by 26
Nayler, S., Powell, J. E., Vanichkina, D., Korn, O., Wells, C. A., Kanjhan, R., Sun, J., Taft, R. J., Lavin, M. F., & Wolvetang, E. J. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00321 · Cited by 26
Familial Alzheimer’s disease modelling using induced pluripotent stem cell technology
Mohamet, L., Miazga, N., & Ward, C. M. (2014) · World Journal of Stem Cells · doi:10.4252/wjsc.v6.i2.239 · Cited by 25
An immune-cell signature marks the brain in Alzheimer’s disease
Heneka, M. T. (2020) · Nature · doi:10.1038/d41586-019-03892-8 · Cited by 24
Multiple sclerosis: getting personal with induced pluripotent stem cells
Ruscio, A. D., Patti, F., Welner, R. S., Tenen, D. G., & Amabile, G. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.179 · Cited by 23
Organotypic Cultures as a Model of Parkinson´s Disease. A Twist to an Old Model
Stahl, K., Skare, Ø., & Torp, R. (2009) · The Scientific World JOURNAL · doi:10.1100/tsw.2009.68 · Cited by 23
Robertson, R. T., Baratta, J. L., Kageyama, G. H., Ha, D. H., & Yu, J. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00067-5 · Cited by 19
Overview of Cell and Tissue Culture Techniques
Honegger, P. (1999) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph1201s04 · Cited by 17
Pfeuffer, S., Ruck, T., Kleinschnitz, C., Wiendl, H., & Meuth, S. G. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1176531 · Cited by 17
Maguire, J. A., Gagne, A. L., Gonzalez‐Alegre, P., Davidson, B. L., Shakkottai, V. G., Gadue, P. J., & French, D. L. (2018) · Stem Cell Research · doi:10.1016/j.scr.2018.101361 · Cited by 17
T cells in Alzheimer's disease: space invaders
McManus, R. M., & Heneka, M. T. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30076-4 · Cited by 15
Simplified Murine 3D Neuronal Cultures for Investigating Neuronal Activity and Neurodegeneration
Collins, S. J., & Haigh, C. L. (2016) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-016-0768-z · Cited by 14
Chew, L., DeBoy, C. A., & Senatorov, V. V. (2014) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2014.08.017 · Cited by 13
Oh, Y. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.6.142 · Cited by 13
[Organotypic culture, on natural and artificial media, of fragments of the adult rat hypophysis].
BOUSQUET, J., & Jm, M. (1962) · PubMed · Cited by 12
Yang, M., Liu, M., Vajda, A., O’Brien, T., Henshall, D. C., Hardiman, O. M., & Shen, S. (2019) · Stem Cell Research · doi:10.1016/j.scr.2019.101558 · Cited by 4
Diagnostic criteria for primary progressive mutiple sclerosis: a position paper.
(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2
Cited by
Solving neurodegeneration: common mechanisms and strategies for new treatments
Wareham, L. K., Liddelow, S. A., Temple, S., Benowitz, L. I., Di Polo, A., Wellington, C., Goldberg, J. L., He, Z., Duan, X., Bu, G., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00524-0 · Cited by 324
Ramos, D. M., Skarnes, W. C., Singleton, A. B., Cookson, M. R., & Ward, M. E. (2021) · Neuron · doi:10.1016/j.neuron.2021.03.022 · Cited by 107
The Potential Role of Cytokines and Growth Factors in the Pathogenesis of Alzheimer’s Disease
Ogunmokun, G., Dewanjee, S., Chakraborty, P., Valupadas, C., Chaudhary, A., Kolli, V., Anand, U., Vallamkondu, J., Goel, P., Paluru, H. P. R., et al. (2021) · Cells · doi:10.3390/cells10102790 · Cited by 85
Kaya, Z. B., Santiago-Padilla, V., Lim, M., Boschen, S. L., Atilla, P., & McLean, P. J. (2024) · Scientific Reports · doi:10.1038/s41598-024-55516-5 · Cited by 58
Arfaei, R., Mikaeili, N., Daj, F., Boroumand, A., Kheyri, A., Yaraghi, P., Shirzad, Z., Keshavarz, M., Hassanshahi, G., Jafarzadeh, A., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112328 · Cited by 27
Metadata
- Authors
- Slanzi, A., Iannoto, G., Rossi, B., Zenaro, E., & Constantin, G.
- Venue
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Published
- 2020-05-13
- Volume
- 8
- Pages
- 328-328
- ISSN
- 2296-634X (ISSN-L)
- OpenAlex
- W3025087901
- Cited by
- 290
- References
- 225
- FWCI
- 13.11
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.